Medication info
Rabeprazole Sodium 20 mg (Rabeprazole Sodium)

Rabeprazole Sodium 20 mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
Pale yellow, round enteric-coated tablets
Packaging
28 tablets (7 tablets/Alu-Alu X 4)
Approval status
Active

MFDS item code 200701491 · Notified 2007.02.02 · Insurance code 644900670

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcer, duodenal ulcer The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually continued for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), an additional 8 weeks of oral administration of 10 mg or 20 mg twice daily may be given. However, 20 mg twice daily should be used only in patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled, if needed, using on-demand therapy with 10 mg once daily. Long-term maintenance therapy for gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients with Helicobacter pylori infection should receive eradication therapy. Concomitant administration of this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to the needs of each patient. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have received this medicine for up to 1 year. Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Elderly patients Use with caution, as hepatic function is often reduced.
Child dose
Safety has not been established in children.

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcers
  • duodenal ulcers
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
  • gastrointestinal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is used to treat gastric ulcers and duodenal ulcers and is effective in alleviating symptoms of erosive or ulcerative gastroesophageal reflux disease. It can also be applied to long-term maintenance therapy for gastroesophageal reflux disease. It is used in combination with antibiotics for the treatment of gastrointestinal ulcers in patients with Helicobacter pylori infection, and it helps with Zollinger-Ellison syndrome. This medication aids in improving gastrointestinal-related diseases.

How to take

Adult dose

Gastric ulcer, duodenal ulcer The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually continued for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), an additional 8 weeks of oral administration of 10 mg or 20 mg twice daily may be given. However, 20 mg twice daily should be used only in patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled, if needed, using on-demand therapy with 10 mg once daily. Long-term maintenance therapy for gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients with Helicobacter pylori infection should receive eradication therapy. Concomitant administration of this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to the needs of each patient. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have received this medicine for up to 1 year. Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Elderly patients Use with caution, as hepatic function is often reduced.

Child dose

Safety has not been established in children.

Precautions

This medication should not be used in patients with allergies to specific components or a history of hypersensitivity. Also, caution is needed as there may be allergic reactions when used with certain antibiotics. Pregnant or nursing women are advised not to take this medication as it may affect the fetus or infant. Patients with poor liver function or the elderly should use this medication cautiously as adverse reactions may occur. If allergic symptoms such as skin rash or itching occur while taking this medication, discontinue immediately. Regular blood tests or liver function tests should be performed, and if abnormalities are found, discontinue use and consult a doctor. Various side effects may occur in multiple body systems including the heart, gastrointestinal, nervous, respiratory, skin, eyes, and urinary system, so it is important to report any unusual symptoms immediately. Long-term use of this medication may increase the risk of fractures, so proper management is required. This medication can interact with other medications, so if you are taking other drugs, be sure to inform your healthcare provider. Caution is required when driving or operating machinery as drowsiness may occur. In case of overdose, there is no specific antidote, so necessary treatment according to the symptoms should be received, and tablets should not be chewed or crushed but swallowed whole. Keep out of reach of children and do not transfer to other containers.

Side effects

Rash, urticaria, itching, decreased red blood cells, decreased white blood cells, increased white blood cells, increased eosinophils, increased neutrophils, decreased lymphocytes, anemia, petechial hemorrhage, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina pectoris, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, supraventricular tachycardia, thrombophlebitis, vasodilation, QTc prolongation, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, hematochezia, anorexia, cholelithiasis, oral ulcer, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stool, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric atony, gastritis, stomatitis, dysgeusia, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, seizures, abnormal dreams, decreased libido, neuropathy, sensory disturbances, tremors, weakness, neurovascular irritability, drowsiness, faintness, depression, anxiety, amnesia, confusion, extrapyramidal syndrome, hypervolemia, weakness of limbs, sensory loss, reduced grip strength, language confusion, staggering, disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, excessive muscle tone, neuralgia, single contraction, sweating, alopecia, dry skin, shingles, psoriasis, skin color changes, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurred vision, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, dysuria, nephrolithiasis, uterine bleeding, polyuria, gynecomastia, elevated total cholesterol, elevated triglycerides, elevated BUN, elevated blood thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, malaise, weight gain, visual disturbances, loss of appetite, neck stiffness, photosensitive reaction, hangover effect, weight loss, gout, anaphylaxis, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, vesicular skin eruption, systemic allergic reaction, arthralgia, interstitial nephritis, gynecomastia, elevated thyroid-stimulating hormone, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, cutaneous lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture and kept at room temperature between 1 degree to 30 degrees Celsius. Proper storage maintains the effectiveness of the medication and allows for safe use.

Appearance and packaging

Appearance

Pale yellow, round enteric-coated tablets

Package unit

28 tablets (7 tablets/Alu-Alu X 4)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.